Taylor L Clark1, Linda Gallo2, Johanna A Euyoque3, Athena Philis-Tsimikas3, Addie Fortmann3. 1. San Diego Joint Doctoral Program in Clinical Psychology, San Diego State University/University of California, San Diego, California. 2. Department of Psychology, San Diego State University, San Diego, California. 3. Scripps Whittier Diabetes Institute, Scripps Health, San Diego, California.
Abstract
PURPOSE: The purpose of this study was to examine whether baseline levels of diabetes distress (DD) impacted clinical benefit from a mobile health (mHealth) diabetes self-management education and support (DSME/S) intervention ("Dulce Digital"). METHODS: This secondary analysis included the full sample of 126 Hispanic adults (mean age = 48.43 years, SD = 9.80) with type 2 diabetes and glycosylated hemoglobin A1C >7.5% enrolled from a Federally Qualified Health Center in a randomized, nonblinded clinical trial that compared Dulce Digital to usual care. Dulce Digital participants received educational/motivational, medication reminders, and blood glucose monitoring prompt text messages over 6 months. RESULTS: Baseline levels of DD prospectively moderated the effect of Dulce Digital (vs usual care) on glycemic control over 6 months, such that Dulce Digital participants with higher DD experienced relatively greater benefit from the intervention. The effect of the intervention on A1C change was 178% larger among individuals experiencing moderate/high versus no/low DD. CONCLUSIONS: Although research has found DD to be associated with poorer self-management and clinical outcomes, individuals already distressed about their diabetes may benefit from a lower-burden mHealth DSME/S approach.
RCT Entities:
PURPOSE: The purpose of this study was to examine whether baseline levels of diabetes distress (DD) impacted clinical benefit from a mobile health (mHealth) diabetes self-management education and support (DSME/S) intervention ("Dulce Digital"). METHODS: This secondary analysis included the full sample of 126 Hispanic adults (mean age = 48.43 years, SD = 9.80) with type 2 diabetes and glycosylated hemoglobin A1C >7.5% enrolled from a Federally Qualified Health Center in a randomized, nonblinded clinical trial that compared Dulce Digital to usual care. Dulce Digital participants received educational/motivational, medication reminders, and blood glucose monitoring prompt text messages over 6 months. RESULTS: Baseline levels of DD prospectively moderated the effect of Dulce Digital (vs usual care) on glycemic control over 6 months, such that Dulce Digital participants with higher DD experienced relatively greater benefit from the intervention. The effect of the intervention on A1C change was 178% larger among individuals experiencing moderate/high versus no/low DD. CONCLUSIONS: Although research has found DD to be associated with poorer self-management and clinical outcomes, individuals already distressed about their diabetes may benefit from a lower-burden mHealth DSME/S approach.
Authors: Sarah Stark Casagrande; Larissa Aviles-Santa; Leonor Corsino; Martha L Daviglus; Linda C Gallo; Rebeca A Espinoza Giacinto; Maria M Llabre; Samantha A Reina; Peter J Savage; Neil Schneiderman; Gregory A Talavera; Catherine C Cowie Journal: Endocr Pract Date: 2017-08-17 Impact factor: 3.443
Authors: William H Polonsky; Lawrence Fisher; Jay Earles; R James Dudl; Joel Lees; Joseph Mullan; Richard A Jackson Journal: Diabetes Care Date: 2005-03 Impact factor: 19.112
Authors: Lisa L Sumlin; Theresa J Garcia; Sharon A Brown; Mary A Winter; Alexandra A García; Adama Brown; Heather E Cuevas Journal: Diabetes Educ Date: 2014-06-17 Impact factor: 2.140
Authors: Deborah Young-Hyman; Mary de Groot; Felicia Hill-Briggs; Jeffrey S Gonzalez; Korey Hood; Mark Peyrot Journal: Diabetes Care Date: 2016-12 Impact factor: 19.112
Authors: Lawrence Fisher; Joseph T Mullan; Patricia Arean; Russell E Glasgow; Danielle Hessler; Umesh Masharani Journal: Diabetes Care Date: 2009-10-16 Impact factor: 19.112